Nonalcoholic fatty liver disease (NAFLD) has emerged as the most common liver disease in pediatrics. NAFLD is a chronic condition that predisposes to the development of cirrhosis and hepatocellular carcinoma. There is a strong link between NAFLD and type 2 diabetes in adults and adolescents, while some studies suggest that subjects with type 1 diabetes might be protected against the development of NAFLD. In this chapter, we review the pathophysiology and the clinical characteristics of NAFLD in pediatric groups as well as the current treatments being tested.

Nonalcoholic Fatty Liver Disease (NAFLD) Association with Pediatric Diabetes

Santoro N.;
2021-01-01

Abstract

Nonalcoholic fatty liver disease (NAFLD) has emerged as the most common liver disease in pediatrics. NAFLD is a chronic condition that predisposes to the development of cirrhosis and hepatocellular carcinoma. There is a strong link between NAFLD and type 2 diabetes in adults and adolescents, while some studies suggest that subjects with type 1 diabetes might be protected against the development of NAFLD. In this chapter, we review the pathophysiology and the clinical characteristics of NAFLD in pediatric groups as well as the current treatments being tested.
978-3-030-64132-0
978-3-030-64133-7
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11695/112548
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact